心脏磁共振在室性心律失常患者中的诊断影响与预后价值
本研究连续纳入因非持续性室性心动过速或持续性室性心动过速/心脏骤停后复苏接受心脏磁共振检查的患者,随访中位4.4年,发现心脏磁共振结构异常在两类患者中分别占40%和66%,且异常心脏磁共振与主要不良心血管事件风险升高相关。
要点
- 非持续性室性心动过速患者中40%心脏磁共振结构异常,持续性室性心动过速/心脏骤停后复苏患者中66%异常。
- 心脏磁共振使27%非持续性室性心动过速患者和41%持续性室性心动过速/心脏骤停后复苏患者诊断发生改变。
- 校正左心室射血分数后,异常心脏磁共振仍与主要不良心血管事件独立相关。
核心结论
- 多参数心脏磁共振评估可为室性心律失常患者提供诊断澄清和有效风险分层,超越当前标准诊疗。
研究设计与样本
- 连续纳入因非持续性室性心动过速(n=345)或持续性室性心动过速/心脏骤停后复苏(n=297)接受心脏磁共振检查的患者,随访中位4.4年;主要不良心血管事件包括死亡、需治疗的复发性室性心动过速/心室颤动和因充血性心力衰竭住院。
关键影像表现/征象
- 心脏磁共振评估显示结构异常心脏在非持续性室性心动过速患者中占40%,在持续性室性心动过速/心脏骤停后复苏患者中占66%(P < 0.001)。
- 心脏磁共振评估使27%的非持续性室性心动过速患者 vs 41%的持续性室性心动过速/心脏骤停后复苏患者诊断发生改变(P < 0.001)。
诊断标准与关键数值
- 非持续性室性心动过速患者中,异常心脏磁共振 vs 正常心脏磁共振的主要不良心血管事件年发生率分别为7.7% vs 0.7%(P < 0.001)。
- 持续性室性心动过速/心脏骤停后复苏患者中,异常心脏磁共振 vs 正常心脏磁共振的主要不良心血管事件年发生率分别为13.3% vs 3.8%(P < 0.001)。
- 多变量模型(含左心室射血分数)中,非持续性室性心动过速患者异常心脏磁共振与主要不良心血管事件的HR为5.23(95% CI:2.28-12.0;P < 0.001)。
- 多变量模型(含左心室射血分数)中,持续性室性心动过速/心脏骤停后复苏患者异常心脏磁共振与主要不良心血管事件的HR为1.88(95% CI:1.07-3.30;P = 0.03)。
- 将心脏磁共振评估加入主要不良心血管事件多变量模型后,非持续性室性心动过速队列的综合判别改善指数显著提高,C统计量也有改善。
临床应用与阅片要点
- 在因室性心律失常接受评估的患者中,多参数心脏磁共振可检出结构异常心脏并提供诊断澄清。
- 异常心脏磁共振与主要不良心血管事件风险升高相关,且在校正左心室射血分数后仍独立相关,可用于风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac magnetic resonance (CMR) characterizes myocardial substrate relevant to sudden cardiac death (SCD). However, its clinical value in patients presenting with ventricular arrhythmias is still being defined.
OBJECTIVES: The authors sought to examine the diagnostic and prognostic value of multiparametric CMR in a cohort of consecutive patients referred for assessment of ventricular arrhythmias.
METHODS: Consecutive patients undergoing CMR for nonsustained ventricular tachycardia (NSVT) (n = 345) or sustained ventricular tachycardia (VT)/aborted SCD (n = 297) were followed over a median of 4.4 years. Major adverse cardiac events included death, recurrent VT/ventricular fibrillation requiring therapy, and hospitalization for congestive heart failure.
RESULTS: Of the 642 patients, 256 were women (40%), mean age was 54 ± 15 years, and median left ventricular ejection fraction was 58% (IQR: 49%-63%). A structurally abnormal heart by CMR assessment was detected in 40% of patients with NSVT and 66% in those with VT/SCD (P < 0.001). CMR assessment yielded a diagnostic change in 27% of NSVT patients vs 41% of those with VT/SCD (P < 0.001). During follow-up, 51 patients (15%) with NSVT and 104 patients (35%) with VT/SCD experienced major adverse cardiac events (MACE). An abnormal CMR was associated with a higher annual rate for MACE for both NSVT (0.7% vs 7.7%; P < 0.001) and VT/SCD (3.8% vs 13.3%; P < 0.001) patients. In a multivariate model including left ventricular ejection fraction, an abnormal CMR remained strongly associated with MACE in NSVT (HR: 5.23 [95% CI: 2.28-12.0]; P < 0.001) and VT/SCD (HR: 1.88 [95% CI: 1.07-3.30]; P = 0.03). Adding CMR assessment to the multivariable model for MACE yielded a significant improvement in the integrated discrimination improvement and an improvement in the C-statistic in the NSVT cohort.
CONCLUSIONS: In patients presenting with ventricular arrhythmias, multiparametric CMR assessment provides diagnostic clarification and effective risk stratification beyond current standard of care.
引用
- Ge, Antiochos, Seno, et al. Diagnostic Impact and Prognostic Value of Cardiac Magnetic Resonance in Patients With Ventricular Arrhythmias. JACC Cardiovasc Imaging. 2023. PMID: 37318392. doi:10.1016/j.jcmg.2023.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。